The grant will allow Dr. Kevin G. Pinney, professor of chemistry and biochemistry in Baylor’s College of Arts and Sciences, and Dr. Mary Lynn Trawick, an associate professor of chemistry and biochemistry, to design, create and test several new potential new cancer fighting compounds that may disrupt solid-cancer tumors and target any remaining tumor cells that may grow after the tumor is treated. The work will be done in collaboration with University of Texas Southwestern Medical Center in Dallas, who will serve as a subcontract on the grant award.
“We are one of the few programs in the world working with these particular compounds and with the collaboration with UT Southwestern, I think this research project was very attractive to NIH,” Pinney said. “This project will give us some deeper insight into these compounds that, in the future, might lead to clinical trials.”
In the first phase of the research, Pinney and Trawick will test three new compounds known as Vascular Disrupting Agents (VDA) that have shown promise in preliminary tests. An emerging area of cancer treatment still in the experimental phase, VDAs target the flow of blood to solid cancer tumors and other abnormal blood vessels while leaving healthy cells intact. The researchers will test these three compounds to see how tolerable they are in animal models and how well the compounds actually disrupt blood flow to the tumor.
The second phase will consist of designing, creating and testing a carefully selected small group of potential new cancer fighting compounds that may disrupt solid-cancer tumors. The Baylor researchers said the main point of emphasis will be on the mechanism of action of the new compounds. Pinney and his research team will be involved with the synthesis and purification of the new potential anticancer VDAs, while Trawick and her research team will evaluate the biochemistry and cell biology.
Finally, the third phase will look into the cell mechanisms of each of the new compounds. The Baylor researchers said many questions remain unanswered, to date, in regard to how VDAs actually function on a molecular level in terms of cell signaling pathways. The study will look at several of these mechanistic questions.
“We will be comparing and studying the cells and proteins to see just how potent they are to cancer which could eventually lead to new drug discovery,” Trawick said. “We are looking at selectivity – how do they disrupt cancer tumors and how well do they do it.”
The study will take about five years to complete.For more information, contact Matt Pene, assistant director of media communications, at (254) 710-4656.
Matt Pene | Newswise Science News
Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses
14.03.2017 | Goethe-Universität Frankfurt am Main
BMBF funding for diabetes research on pancreas chip
08.02.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Physics and Astronomy
24.03.2017 | Materials Sciences
24.03.2017 | Health and Medicine